Logo

American Heart Association

  2
  0


Final ID: Mo2076

Relationships Between Degree of Obesity, Transthoracic Impedance, and Cardioversion Efficacy

Abstract Body (Do not enter title and authors here): Background:
In our recent multicenter randomized clinical trial comparing the efficacy of single versus dual direct current cardioversion (DCCV) in patients with significant obesity (body mass index [BMI] ≥35 kg/m2) undergoing DCCV for atrial fibrillation (AF), we found higher success rates using dual-DCCV. In addition to total energy applied, another important parameter is transthoracic impedance (TTI), as it impacts myocardial current density. Higher TTI is associated with DCCV failure. Previous studies found a positive correlation between BMI and TTI among normal-BMI patients (B=1.9 Ω/[kg/m2]). Whether there is a significant relationship between BMI and TTI in obese patients is unknown.

Objective:
In this post-hoc analysis of the dual-DCCV study, we investigated whether further increase in BMI above 35 kg/m2 correlates with increasing TTI, and whether TTI impacts procedural success in obese patients.

Methods:
Of the 200 patients included in the primary study, impedance data were available for 112. The relationship between BMI and TTI was compared using linear regression, and t-tests were used to assess whether DCCV efficacy varied significantly with BMI or TTI.

Results:
Among these 112 patients (age 65±11 years, BMI 41±7 kg/m2, 36 [32%] female, 17 [15%] Black), increasing BMI was weakly associated with a small, though statistically significant, increase in TTI (R2=0.04, B=0.53, p=0.03). There was no difference between patients with successful cardioversion (n=101) vs. failure (n=11) in terms of BMI (41±6 vs. 44±14 kg/m2, p=0.16) or TTI (96±19 vs. 98±18 Ω, p=0.81). These relationships were also true when the analysis was limited to participants receiving single-DCCV (n=57; with success in 48 [84%]): 41±6 vs. 45±15 kg/m2, p=0.21; and 98±15 vs. 102±17 Ω, p=0.48.

Conclusion:
In patients with Class 2 or higher obesity undergoing DCCV, there is a weaker association between further increase in BMI and TTI than previously found among patients with BMI <35 kg/m2. Further, in this high BMI population, there is no difference in TTI or BMI based on success or failure of DCCV.
  • Sanchez, Alexandra  ( Ochsner Health , New Orleans , Louisiana , United States )
  • Morin, Daniel  ( Ochsner Health , New Orleans , Louisiana , United States )
  • Murphy, Barret  ( Ochsner Health , New Orleans , Louisiana , United States )
  • Aymond, Joshua  ( Ochsner Health , New Orleans , Louisiana , United States )
  • Bernard, Michael  ( Ochsner Health , New orleans , Louisiana , United States )
  • Hiltbold, Aimee  ( Ochsner Health , New Orleans , Louisiana , United States )
  • Khatib, Sammy  ( Ochsner Health , New orleans , Louisiana , United States )
  • Polin, Glenn  ( Ochsner Health , New Orleans , Louisiana , United States )
  • Rogers, Paul  ( Ochsner Health , New Orleans , Louisiana , United States )
  • Castine, Michael  ( Ochsner Health , New Orleans , Louisiana , United States )
  • Author Disclosures:
    Alexandra Sanchez: DO NOT have relevant financial relationships | Daniel Morin: DO have relevant financial relationships ; Researcher:Abbott:Past (completed) ; Speaker:Medtronic:Past (completed) ; Speaker:Boston Scientific:Past (completed) ; Speaker:Abbott:Past (completed) ; Speaker:Zoll:Active (exists now) | Barret Murphy: No Answer | Joshua Aymond: DO NOT have relevant financial relationships | Michael Bernard: No Answer | Aimee Hiltbold: No Answer | Sammy Khatib: No Answer | GLENN POLIN: No Answer | PAUL ROGERS: No Answer | Michael Castine: DO have relevant financial relationships ; Speaker:Zoll:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

An Atrial Fibrillation Assortment: Populations, Trends, and Outcomes

Monday, 11/18/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
Population-based Study of Stroke Recurrence in Overweight or Obese Patients: Considerations for Future Prevention Trials

Yahnke Ian, Demel Stacie, Mistry Eva, Coleman Elisheva, Jasne Adam, Slavin Sabreena, Walsh Kyle, Star Michael, Stanton Robert, Ljungberg Lovisa, Kamel Hooman, Sucharew Heidi, Haverbusch Mary, Kissela Brett, Broderick Joseph, Robinson David, Kleindorfer Dawn, Ferioli Simona, Mackey Jason, Woo Daniel, Delosrioslarosa Felipe

Cardiometabolic Risk during the Venezuelan Humanitarian Crisis: Insights from the EVESCAM Study on Crisis Indicators.

Nieto-martinez Ramfis, De Oliveira Gomes Diana, Gonzalez Rivas Juan, Ugel Eunice, Duran Maritza, Marulanda Maria, Franceschi Jimenez Luis Arturo, Mechanick Jeffrey, Danaei Goodarz

You have to be authorized to contact abstract author. Please, Login
Not Available